CL2014003549A1 - Producción de cultivos protozoarios de histomonas meleagridis; y formulación de vacuna que comprende un cultivo atenuado de h. meleagridis y al menos un cultivo bacteriano de una cepa única. - Google Patents

Producción de cultivos protozoarios de histomonas meleagridis; y formulación de vacuna que comprende un cultivo atenuado de h. meleagridis y al menos un cultivo bacteriano de una cepa única.

Info

Publication number
CL2014003549A1
CL2014003549A1 CL2014003549A CL2014003549A CL2014003549A1 CL 2014003549 A1 CL2014003549 A1 CL 2014003549A1 CL 2014003549 A CL2014003549 A CL 2014003549A CL 2014003549 A CL2014003549 A CL 2014003549A CL 2014003549 A1 CL2014003549 A1 CL 2014003549A1
Authority
CL
Chile
Prior art keywords
meleagridis
culture
production
vaccine formulation
single strain
Prior art date
Application number
CL2014003549A
Other languages
English (en)
Inventor
Michael Hess
Petra Ganas
Original Assignee
Veterinärmedizinische Universität Wien
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veterinärmedizinische Universität Wien filed Critical Veterinärmedizinische Universität Wien
Publication of CL2014003549A1 publication Critical patent/CL2014003549A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/68—Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CL2014003549A 2012-07-02 2014-12-29 Producción de cultivos protozoarios de histomonas meleagridis; y formulación de vacuna que comprende un cultivo atenuado de h. meleagridis y al menos un cultivo bacteriano de una cepa única. CL2014003549A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12174582.2A EP2682457A1 (en) 2012-07-02 2012-07-02 Production and application of protozoa cultures of Histomonas meleagridis (H. meleagridis)

Publications (1)

Publication Number Publication Date
CL2014003549A1 true CL2014003549A1 (es) 2015-08-07

Family

ID=48793189

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014003549A CL2014003549A1 (es) 2012-07-02 2014-12-29 Producción de cultivos protozoarios de histomonas meleagridis; y formulación de vacuna que comprende un cultivo atenuado de h. meleagridis y al menos un cultivo bacteriano de una cepa única.

Country Status (11)

Country Link
US (2) US9833501B2 (es)
EP (2) EP2682457A1 (es)
JP (2) JP6386452B2 (es)
CN (1) CN104471054A (es)
AU (1) AU2013286002B2 (es)
BR (1) BR112014032937A2 (es)
CA (1) CA2877539A1 (es)
CL (1) CL2014003549A1 (es)
ES (1) ES2893834T3 (es)
MX (1) MX363037B (es)
WO (1) WO2014006018A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108633843B (zh) * 2018-04-18 2020-10-27 中国科学院水生生物研究所 一种鲩肠袋虫的体外培养方法及使用的培养基的制备方法
CN110616149A (zh) * 2019-10-11 2019-12-27 扬州大学 一种鸡源火鸡组织滴虫传代致弱株、其制备方法及用途
CN112322765B (zh) * 2020-10-15 2022-11-22 山东省农业科学院家禽研究所（山东省无特定病原鸡研究中心） 快速检测鸡球虫与组织滴虫的特异性引物、试剂盒及方法
EP4112717A1 (en) 2021-06-29 2023-01-04 Veterinärmedizinische Universität Wien Attenuated histomonas meleagridis strain and vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT502702B1 (de) 2005-05-12 2008-05-15 Veterinaermedizinische Uni Wie Verfahren zur herstellung und anwendung von protozoenkulturen

Also Published As

Publication number Publication date
EP2867356B1 (en) 2021-08-18
WO2014006018A1 (en) 2014-01-09
US9833501B2 (en) 2017-12-05
US20180117131A1 (en) 2018-05-03
CA2877539A1 (en) 2014-01-09
MX2014016016A (es) 2015-12-07
US10350281B2 (en) 2019-07-16
EP2867356A1 (en) 2015-05-06
CN104471054A (zh) 2015-03-25
EP2682457A1 (en) 2014-01-08
AU2013286002B2 (en) 2019-01-31
JP2015522269A (ja) 2015-08-06
ES2893834T3 (es) 2022-02-10
JP2018148893A (ja) 2018-09-27
AU2013286002A1 (en) 2015-01-22
US20150157698A1 (en) 2015-06-11
MX363037B (es) 2019-03-01
BR112014032937A2 (pt) 2017-08-01
JP6386452B2 (ja) 2018-09-05

Similar Documents

Publication Publication Date Title
CO7020854A2 (es) Cepa bacteriana aislada del género burkholderia y metabolitos plaguicidas derivados-formulaciones y usos
CL2015001054A1 (es) Métodos de cultivo de microorganismos en condiciones mixotrópicas no axénicas.
CL2014003035A1 (es) Compuestos derivados de diazabiciclooctano, inhibidores de beta-lactamasa; composicion farmaceutica que los comprende; proceso para prepararlos; y metodo para tratar una infeccion bacteriana.
CL2014002053A1 (es) Composición pesticida que comprende un compuesto derivado de una hidrazinacarbotioamida; y proceso de aplicación.
UY34607A (es) Plantas resistentes al glifosato y métodos asociados.
BR112013018836A2 (pt) "métodos de manipulação, obtenção, elevação e aumento em uma planta que compreende a expressão de gene modificado"
CL2014000919A1 (es) Compuestos derivados de acido 2-tert-butoxi-2-(5-metilbenzo[d]tiazol-6-il) acetico; composicion farmaceutica que los comprende; metodo para tratar una infeccion por vih; y su uso para tratar una infeccion por vih.
MX348003B (es) Metodos y medios para modificar un genoma vegetal.
BR112013011881A2 (pt) micro-organismos probióticos não replicantes que protegem contra infecções do trato respiratório superior
GB2482536B (en) Expression of antibody or a fragment thereof in lactobacillus
CL2015003479A1 (es) Métodos y composiciones de fermentación bacterial.
EP2764102A4 (en) METHOD AND COMPOSITIONS FOR REGULATING HIV INFECTIONS
RU2011134931A (ru) Штамм enterococcus, используемый для приготовления кисломолочных напитков
BR112014002624A2 (pt) microorganismo recombinante e cultura de microorganismo recombinante
CL2014003549A1 (es) Producción de cultivos protozoarios de histomonas meleagridis; y formulación de vacuna que comprende un cultivo atenuado de h. meleagridis y al menos un cultivo bacteriano de una cepa única.
WO2012019054A3 (en) Expression of antibody or a fragment thereof in lactobacillus
CO7151478A2 (es) Formulaciones estabilizadas que contienen anticuerpos anti-dll4
CL2012002902A1 (es) Cepas de bacteriofagos especifica contra bacterias pertenecientes al genero vibrio para la profilaxis y terapia de vibrio anguillarum; y composicion antibacteriana que comprende dicha cepas.
CO6791610A2 (es) Preparaciones que contienen antraquinona /formulaciones de lignina
WO2013123046A3 (en) Cathode buffer materials and related devices and methods
CO7200262A2 (es) Nueva dosificación y formulación
UA112760C2 (uk) Теобромін у комбінації з гвайфенезином для лікування кашлю
GB2515222A (en) Use of flagellin as a vaccine
EP3069591A4 (en) Bioreactor for in vitro plant culture
HK1211629A1 (en) Biological culture of a strain of the species pseudomonas graminis and use of said culture as antagonist for the biocontrol of pathogenic bacteria